IL⁃17A secreted by Th17 cells recruited by CXCL16 against B⁃ALL cell apoptosis
Received date: 2023-09-25
Online published: 2024-01-10
目的 探讨辅助性T细胞17(T helper cell 17,Th17)对急性B淋巴细胞白血病(B cell-acute lymphoblastic leukemia, B-ALL)进展的影响及可能的作用机制。 方法 构建B-ALL小鼠模型。采用流式细胞术检测B-ALL小鼠外周血、骨髓、脾脏和淋巴结Th17细胞的比例。进一步通过细胞因子芯片分析B-ALL小鼠外周血细胞因子的表达情况,采用ELISA验证B-ALL小鼠外周血细胞IL-17A的表达。Th17细胞与白血病细胞共培养,通过流式细胞术检测Ki-67阳性细胞和B-ALL细胞凋亡比例,分析B-All细胞对Th17细胞的招募作用;通过Westernblot检测凋亡相关蛋白的表达。通过体内人急性白血病小鼠模型评价Th17细胞通过分泌IL-17A 促B-ALL进展。 结果 Th17细胞在B-ALL小鼠外周血(P < 0.000 1)、骨髓(P < 0.000 1)、脾脏(P < 0.000 1)和淋巴结(P < 0.000 1)中升高。IL-17A在B-ALL模型小鼠外周血中表达升高(P < 0.000 1),Th17细胞通过IL-17A促进B-All细胞增殖(P < 0.000 1),抑制其凋亡(P < 0.000 1)。B-All细胞通过CXCL16招募Th17细胞(P < 0.000 1)。体内动物实验结果表明,IL-17A处理显著增加了人急性白血病小鼠外周血、骨髓和脾脏中的白血病细胞比例,并缩短其生存时间。 结论 Th17细胞在B-ALL中比例升高,B-All细胞通过CXCL16招募Th17细胞,Th17细胞分泌IL-17A 促B-All进展。
李艳超 , 任巧利 . CXCL16募集Th17细胞分泌IL-17A抗急性B淋巴细胞白血病细胞凋亡的实验研究[J]. 实用医学杂志, 2023 , 39(24) : 3163 -3168 . DOI: 10.3969/j.issn.1006-5725.2023.24.003
Objective To investigate the effect of T helper cell 17(Th17)on the progression of B cell?acute lymphoblastic leukemia (B?ALL)and its possible mechanism. Methods We established the B?ALL mouse model and detected the proportion of Th17 cells in peripheral blood, bone marrow, spleen and lymph nodes by flow cytometry. Further, we used cytokine microarray to analyze the expression of cytokine in peripheral blood of B?ALL mice, and used ELISA to verify the IL?17A expression in peripheral blood of B?ALL mice. Th17 cells were co?cultured with leukemia cells, and the apoptosis ratio of Ki?67 positive cells and B?ALL cells was detected by flow cytometry, the recruitment effect of B?All cells on Th17 cells was analyzed. The expression of apoptosis?related proteins was detected by Western blot. The development of B?ALL by secreting IL-17A from Th17 cells was evaluated in vivo in a mouse model of human acute leukemia. Results Th17 cells were increased in peripheral blood(P < 0.000 1), bone marrow(P < 0.000 1), spleen (P < 0.000 1) and lymph nodes (P < 0.000 1) of B?ALL mice. The expression of IL?17A was increased in peripheral blood of B?ALL model mice (P < 0.000 1), and Th17 cells promoted the proliferation of B?All cells and inhibited their apoptosis through IL?17A (P < 0.000 1). B?All cells recruit Th17 cells through CXCL16(P < 0.000 1). The animal experiments showed that IL?17A treatment significantly increased the proportion of leukemia cells in peripheral blood, bone marrow and spleen of B?ALL mice, and shortened their survival time. Conclusion The proportion of Th17 cells in B?ALL increases, B?All cells recruit Th17 cells through CXCL16, and Th17 cells secrete IL-17A to promote B?All progression.
Key words: B cell?acute lymphoblastic leukemia; Th17; IL-17A; cell apoptosis; mice; experimental study
| 1 | TRAN T H, HUNGER S P. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities[J]. Semin Cancer Biol, 2022,84:144-152. |
| 2 | JEDRASZEK K, MALCZEWSKA M, PARYSEK-WóJCIK K. Resistance Mechanisms in Pediatric B-Cell Acute Lymphoblastic Leukemia[J]. Int J Mol Sci, 2022,23(6):3067. |
| 3 | LEE M, HAMILTON J A G, TALEKAR G R. Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia[J]. Nat Commun, 2022,13(1):1157. |
| 4 | 刘彤,银维谋,蓝娇,等. 哮喘小鼠CCR4/TARC信号轴对Treg/Th17细胞平衡的调控研究[J]. 实用医学杂志, 2020,36(19):2621-2624,2629. |
| 5 | BI L, WU J, YE A. Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signaling[J]. J Transl Med, 2016,14(1):132. |
| 6 | CHEN H, PAN Y, ZHOU Q. METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer[J]. Gastroenterology, 2022,163(4):891-907. |
| 7 | SKROBLYN T, JOEDICKE J J, PFAU M. CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment[J]. J Pathol, 2022,258(1):12-25. |
| 8 | KERR M W A,MAGALH?ES-GAMAF, IBIAPINA H N S,et al. Bone Marrow Soluble Immunological Mediators as Clinical Prognosis Biomarkers in B-Cell Acute Lymphoblastic Leukemia Patients Undergoing Induction Therapy[J]. Front Oncol, 2021,11:696032. |
| 9 | RATTI S, LONETTI A, FOLLO M Y. B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?[J]. Cancers (Basel), 2020,12(12):3498. |
| 10 | HODBY K A, MARKS D I. Recent Advances in the Management of Acute Lymphoblastic Leukaemia[J]. Curr Treat Options Oncol, 2020,21(3):23. |
| 11 | GAUDICHON J, JAKOBCZYK H, DEBAIZE L. Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues[J]. Blood Rev,2019,36:40-56. |
| 12 | SALAZAR Y, ZHENG X, BRUNN D. Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer[J]. J Clin Invest, 2020,130(7):3560-3575. |
| 13 | 刘琳,李润荣,龚时鹏. 聚乙二醇化重组人粒细胞刺激因子预防卵巢上皮性癌多柔吡星联合卡铂化疗后粒细胞减少症的临床疗效及安全性[J]. 实用医学杂志,2023,39(17):2236-2240. |
| 14 | 马晶晶,曹梦璐,姚雨君,等. 长、短效重组人粒细胞刺激因子对恶性肿瘤患者多周期化疗后白细胞减少症的有效性研究[J]. 实用医学杂志, 2020,36(20):2815-2819. |
/
| 〈 |
|
〉 |